![]() |
|
|
Vol. 291, Issue 3, 925-931, December 1999
Department of Pharmacology and Toxicology, West Virginia University
School of Medicine, Morgantown, West Virginia
In the 1960s, it became clear that the adaptation of smooth muscle to
denervation was different from that of skeletal muscle. The
supersensitivity of denervated smooth muscle extended to agonists unrelated to the lost neurotransmitter and developed on a
tissue-dependent time course of several days to several weeks. Several
procedures, in addition to denervation, that interrupted excitatory
transmission, elicited the phenomenon. The supersensitivity occurred
without changes in density or affinity of receptors but correlated with a partial depolarization of the smooth muscle cells. The phenomenon could be mimicked by procedures that acutely depolarized the cells. Electrophysiological, biochemical, and molecular data established that
the depolarization was due to reduced electrogenic pumping and reduced
density of the Na+,K+ pump. The triggering
event for the development of such supersensitivity is not interruption
of contact of neurotransmitter with its receptor, but rather the
decreased activity of the adapting cells. This is clear from the fact
that the inhibitory action of opioids produces similar sensitivity
changes in several different populations of guinea pig neurons,
including S-type neurons of the myenteric plexus. Subcutaneous
implantation of morphine pellets in guinea pigs induces adaptation of S
neurons expressed as nonspecific subsensitivity to inhibitory agonists
(opioids,
2-adrenoceptor agonists, 2-chloroadenosine)
and supersensitivity to excitatory agonists (nicotine,
5-hydroxytryptamine, K+). These changes are accompanied by
a partial depolarization of the S neurons and decreased electrogenic
Na+,K+ pumping. Chronic implantation of
morphine pellets also produces similar nonspecific changes in
sensitivity in neurons of the nucleus tractus solitarius and locus
ceruleus. It is suggested that depressed activity of these neurons
leads to an electrophysiological adaptation, presumably due to reduced
density of Na+,K+ pump proteins, as
demonstrated in smooth muscle.
This article has been cited by other articles:
![]() |
A. R. Gintzler and S. Chakrabarti The Ambiguities of Opioid Tolerance Mechanisms: Barriers to Pain Therapeutics or New Pain Therapeutic Possibilities J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 709 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Taylor and W. W. Fleming Unifying Perspectives of the Mechanisms Underlying the Development of Tolerance and Physical Dependence to Opioids J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 11 - 18. [Abstract] [Full Text] |
||||